Definitive Contract 75N91019C00014
Award Date
9/16/19
Potential Completion Date
9/15/21
Potential Value
$300K
Federal Agency
National Cancer Institute
Awardee
Columbus Nanoworks, Inc.
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
GRANDVIEW, OH 43212, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
95
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This $354,994.00 federal contract award was made by the National Cancer Institute (NCI) to Columbus Nanoworks, Inc., a small business biotechnology research company, for a Phase I Small Business Innovation Research (SBIR) project titled "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)." The project is focused on developing a quantum-based diagnostic for microRNA in inflammatory breast cancer, which aligns with NCI's broader research objectives in cancer diagnostics and...
This is a $1,499,656.00 Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services (HHS), to Columbus Nanoworks, Inc., a small business manufacturer of nanomaterials. The contract is for the development of fluorescent nanodiamonds for in vitro and in vivo biological imaging, under the Small Business Innovation Research (SBIR) program. The work will be performed primarily in Grandview, Ohio. This...
This contract, valued at $199,952.00, was awarded by the National Cancer Institute (NCI) to Luna Innovations Incorporated, a small business contractor, under the Small Business Innovation Research (SBIR) program. The contract supports the development of a multifunctional nanodevice for targeted cancer MRI imaging and therapy. Luna Innovations will collaborate with The Washington University, a subcontractor, to perform MRI scans and tissue analysis. This project contributes to NCI's mission in...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
This definitive firm fixed price contract from the Department of Health and Human Services National Institutes of Health National Cancer Institute, with a total small business set aside, is for $299,726.89 to Imago Systems Inc. for the development of a novel diagnostic imaging modality for monitoring tumor responses to a hyperthermia immunotherapy as part of the National Cancer Institute's Moonshot initiative. The award stems from Topic 375 of the NIH/CDC SBIR Contract Solicitation PHS 2018-1,...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Imaginab, Inc. The contract, valued at $224,264, is for the development of novel imaging agents to expand the clinical toolkit for cancer diagnosis, staging, and treatment. The contract has a firm fixed-price pricing type and a completion date of September 29, 2012.</p>
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanotarget LLC for the development of a nanoparticle CD8 T cell regimen for cancer therapy. The firm-fixed-price contract has a ceiling value of $174,251 and a period of performance ending on May 31, 2010. No subcontractors are mentioned. The SBIR program supports research and development of innovative technologies by small businesses to address key...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...